ADIA Boosted Direct Mainland China Holdings Earlier in 2021
Posted on 09/16/2021
The Abu Dhabi Investment Authority (ADIA) boosted holdings in mainland Chinese stocks in the first half of 2021, according to stock filing data in China. ADIA acquired large positions in A-shares and increased exposure to the Chinese industries of consumer, financial brokerage, and pharmaceuticals. ADIA’s shareholder ranking in the QFII program ranks fifth.
Some of the companies in which ADIA appears as a top shareholder include: Shanghai Pharmaceuticals (Shanghai Industrial Pharmaceutical Investment Co. Ltd.), Tonghua Dongbao Pharmaceutical Co Ltd, Shijiazhuang Yiling Pharmaceutical Co Ltd, Laobaixing Pharmacy Chain JSC, Joincare Pharmaceutical Group Industry Co.,Ltd., and Jinyu Bio-Technology Co Ltd.
Other positions were in China Molybdenum Co Ltd, Nanjing Iron & Steel Co.,Ltd., Bestechnic (Shanghai) Co., Ltd., Proya Cosmetics, Jonjee Hi-Tech Industrial And…